Weight-loss drugs are booming in these US states — with nearly 25% on GLP-1 meds in one obesity hot spot
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the US, with some states seeing greater uptick than others. Based on insurance claims data from Purple Lab, a Pennsylvania … Read more